The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
RANKL as the master regulator of osteoclast differentiation
Abstract
RANKL, the essential cue for osteoclast differentiation, is the membrane-bound factor expressed by osteoclastogenesis-supporting cells such as osteoblasts and osteocytes. In vivo evidence indicates that RANKL functions as the indispensable and irreplaceable in the program of osteoclast differentiation. The reason why RANKL plays a critical role in osteoclastogenesis is discussed from the viewpoint of the distinct signaling pathways mediated by co-stimulatory receptors and the key transcription factor NFATc1.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mechanistically, M-CSF and RANKL bind to their receptors CSF1R and RANK, respectively, and stimulate downstream signaling pathways such as MAPKs and NF-κB, leading to the activation of master transcription factors including PU.1 and NFATc1, initiating osteoclastogenesis9,10.”
From Targeting Msx2 as a brake in the fusion fate of osteoclasts and an anabolic therapy in pre-clinical models of osteoporosis (2025) · cites this paper as [10]
Citations
Cites
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439
Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3597 · Cited by 4,224
Regulation of type I interferon responses
Ivashkiv, L. B., & Donlin, L. T. (2013) · Nature reviews. Immunology · doi:10.1038/nri3581 · Cited by 3,442
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis.
Kong, Y.-Y., Yoshida, H., Sarosi, I., Tan, H.-L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., et al. (1999) · Nature · doi:10.1038/16852 · Cited by 3,351
Takayanagi, H., Kim, S., Koga, T., Nishina, H., Isshiki, M., Yoshida, H., Saiura, A., Isobe, M., Yokochi, T., Inoue, J.-I., et al. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00369-6 · Cited by 2,701
Self-citationKulkarni, A. B., Huh, C. G., Becker, D., Geiser, A., Lyght, M., Flanders, K. C., Roberts, A. B., Sporn, M. B., Ward, J. M., & Karlsson, S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.2.770 · Cited by 1,967
Yoshida, H., Hayashi, S.-I., Kunisada, T., Ogawa, M., Nishikawa, S., Okamura, H., Sudo, T., Shultz, L. D., & Nishikawa, S.-I. (1990) · Nature · doi:10.1038/345442a0 · Cited by 1,789
Evidence for osteocyte regulation of bone homeostasis through RANKL expression
Nakashima, T., Hayashi, M., Fukunaga, T., Kurata, K., Oh-hora, M., Feng, J. Q., Bonewald, L. F., Kodama, T., Wutz, A., Wagner, E. F., et al. (2011) · Nature Medicine · doi:10.1038/nm.2452 · Cited by 1,778
Self-citationGenetic regulation of osteoclast development and function
Teitelbaum, S. L., & Ross, F. P. (2003) · Nature Reviews Genetics · doi:10.1038/nrg1122 · Cited by 1,720
RANK is essential for osteoclast and lymph node development.
Dougall, W. C., Glaccum, M., Charrier, K., Rohrbach, K., Brasel, K., De Smedt, T., Daro, E., Smith, J., Tometsko, M. E., Maliszewski, C. R., et al. (1999) · Genes & Development · doi:10.1101/gad.13.18.2412 · Cited by 1,478
Cited by
Sorted by citations
The Macrophage-Osteoclast Axis in Osteoimmunity and Osteo-Related Diseases
Yao, Y., Cai, X. T., Ren, F., Ye, Y., Wang, F., Zheng, C., Qian, Y., & Zhang, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.664871 · Cited by 235
The RANK/RANKL/OPG system and tumor bone metastasis: Potential mechanisms and therapeutic strategies
Zhang, Y., Liang, J., Liu, P., Wang, Q., Liu, L., & Zhao, H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1063815 · Cited by 111
Xue, C., Luo, H., Wang, L., Deng, Q., Kui, W., Da, W., Chen, L., Liu, S., Xue, Y., Yang, J., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1234563 · Cited by 70
Long noncoding RNA Malat1 protects against osteoporosis and bone metastasis
Zhao, Y., Ning, J., Teng, H., Deng, Y., Sheldon, M., Shi, L., Martinez, C., Zhang, J., Tian, A., Sun, Y., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46602-3 · Cited by 69
Faqeer, A., Wang, M., Alam, G., Padhiar, A. A., Zheng, D., Luo, Z., Zhao, I. S., Zhou, G., van den Beucken, J. J. J. P., Wang, H., et al. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122367 · Cited by 62
The role of TNF-α in osteoporosis, bone repair and inflammatory bone diseases: A review
yao, Q., He, L., Bao, C., yan, X., & Jun, A. (2024) · Tissue and Cell · doi:10.1016/j.tice.2024.102422 · Cited by 57
Zhang, J., Zhang, L., Yao, G., Zhao, H., & Wu, S. (2023) · Cell Biology and Toxicology · doi:10.1007/s10565-023-09834-5 · Cited by 55
Si, Y., Li, Y., Gu, K., Yin, H., & Ma, Y. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116422 · Cited by 57
Xu, Y. Y., Song, D., Su, Y., Chen, J., Wu, L., Lian, H., Hai, N., Li, J., Jiang, J., Zhao, J., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.114101 · Cited by 51
The immunological significance of tumor necrosis factor receptor-associated factors (TRAFs)
So, T. (2021) · International Immunology · doi:10.1093/intimm/dxab058 · Cited by 55
The monocyte-to-osteoclast transition in rheumatoid arthritis: Recent findings
Iwamoto, N., & Kawakami, A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.998554 · Cited by 45
Research Progress on Biomaterials with Immunomodulatory Effects in Bone Regeneration
Li, J., Qu, Y., Chu, B., Wu, T., Pan, M., Mo, D., Li, L., Ming, Y., Yang, Y. S., Wang, M., et al. (2025) · Advanced Science · doi:10.1002/advs.202501209 · Cited by 50
Su, Z., Yao, B., Liu, G., & Fang, J. Q. (2023) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2023.109488 · Cited by 49
Osteoclast biology in the single-cell era
Tsukasaki, M., & Takayanagi, H. (2022) · Inflammation and Regeneration · doi:10.1186/s41232-022-00213-x · Cited by 53
Self-citationRedox signaling and antioxidant defense in osteoclasts
Tao, H., Li, X., Wang, Q., Yu, L., Peng, Y., Chen, W., Yang, X., Zhou, J., & Geng, D. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2023.12.043 · Cited by 40
Subchondral osteoclasts and osteoarthritis: new insights and potential therapeutic avenues
Chen, W., Wang, Q., Tao, H., Lu, L., Zhou, J., Wang, Q., Huang, W., & Yang, X. H. (2024) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2024017 · Cited by 35
Si, Y., Dong, S., Li, M., Gu, J., Luo, M., Wang, X., Wang, Z., Li, X., & Zhang, C. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.101874 · Cited by 35
Small-molecule amines: a big role in the regulation of bone homeostasis
Zhang, Q., Yang, J., Hu, N., Liu, J., Yu, H., Pan, H., Chen, D., & Ruan, C. (2023) · Bone Research · doi:10.1038/s41413-023-00262-z · Cited by 34
Profiling joint tissues at single-cell resolution: advances and insights
Pandey, A., & Bhutani, N. (2023) · Nature Reviews Rheumatology · doi:10.1038/s41584-023-01052-x · Cited by 34
Feng, X., Liu, Z., Su, Y., Lian, H., Gao, Y., Zhao, J., Xu, J., Liu, Q., & Song, F. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115895 · Cited by 31
Review of potential medical treatments for middle ear cholesteatoma
Schürmann, M., Goon, P. K. C., & Sudhoff, H. H. (2022) · Cell Communication and Signaling · doi:10.1186/s12964-022-00953-w · Cited by 31
Yao, H., Xiang, L., Huang, Y., Tan, J., Shen, Y., Li, F., Geng, F., Li, X., Li, X., & Gao, Y. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154967 · Cited by 29
Neutrophils in Inflammatory Bone Diseases
Carmona‐Rivera, C., Kaplan, M. J., & O’Neil, L. J. (2024) · Current Osteoporosis Reports · doi:10.1007/s11914-024-00865-3 · Cited by 28
Jann, J.-C., Mossner, M., Riabov, V., Altrock, E., Schmitt, N., Flach, J., Xu, Q., Nowak, V., Obländer, J., Palme, I., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26424-3 · Cited by 26
Lu, H., Tan, Y., Zhang, Y.-T. Y., Li, Z., Chen, J., Gao, C., Liu, Y., & Luo, X. (2022) · Fitoterapia · doi:10.1016/j.fitote.2022.105201 · Cited by 24
Lu, T., Yuan, X., Zhang, L., He, F., Wang, X., & Ye, J. (2023) · Materials Today Chemistry · doi:10.1016/j.mtchem.2023.101410 · Cited by 24
Circadian clock genes as promising therapeutic targets for bone loss
Qin, Y., Chen, Z.-H., Wu, J.-J., Zhang, Z., Yuan, Z., Guo, D., Chen, M.-N., Li, X., & Yuan, F. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.114019 · Cited by 25
Puerarin alleviates cadmium‐induced oxidative damage to bone by reducing autophagy in rats
Tong, X., Yu, G., Liu, Q., Zhang, X., Bian, J., Liu, Z., & Gu, J. (2021) · Environmental Toxicology · doi:10.1002/tox.23437 · Cited by 23
He, M., Li, D., Fang, C., & Xu, Q. (2022) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2022.109464 · Cited by 22
Discovery of a First-in-Class GPR183 Antagonist for the Potential Treatment of Rheumatoid Arthritis
Xi, J., Gong, H., Li, Z., Li, Y., Wu, Y., Zhang, Y., Wang, J., & Fan, G.-H. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c01364 · Cited by 19
Multinucleation resets human macrophages for specialized functions at the expense of their identity
Ahmadzadeh, K., Pereira, M., Vanoppen, M., Bernaerts, E., Ko, J., Mitera, T., Maksoudian, C., Manshian, B. B., Soenen, S. J., Rosé, C. D., et al. (2023) · EMBO Reports · doi:10.15252/embr.202256310 · Cited by 22
Jeong, H., Byun, H., Lee, J., Han, Y., Huh, S. J., & Shin, H. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202400232 · Cited by 20
Extra-osseous Roles of the RANK-RANKL-OPG Axis with a Focus on Skeletal Muscle
Gostage, J., Kostenuik, P. J., Goljanek‐Whysall, K., Bellantuono, I., McCloskey, E. V., & Bonnet, N. (2024) · Current Osteoporosis Reports · doi:10.1007/s11914-024-00890-2 · Cited by 21
New Function of Cholesterol Oxidation Products Involved in Osteoporosis Pathogenesis
Che, Y., Yang, J., Tang, F., Wei, Z., Chao, Y., Li, N., Li, H., Wu, S., & Dong, X. W. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042020 · Cited by 20
Qu, Z., An, H., Feng, M., Huang, W., Wang, D., Zhang, Z., & Yan, L. W. (2022) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17467 · Cited by 20
Shi, X., Wu, Y., Tang, L., Yin, Z., Shi, J. Y., Wu, X., & Xu, Y. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.155337 · Cited by 19
Porous 3D Scaffolds Enhance MSC Vitality and Reduce Osteoclast Activity
Spreda, M., Hauptmann, N., Lehner, V., Biehl, C., Liefeith, K., & Lips, K. S. (2021) · Molecules · doi:10.3390/molecules26206258 · Cited by 19
Bone and the Unfolded Protein Response: In Sickness and in Health
Iyer, S. V., & Adams, D. J. (2023) · Calcified Tissue International · doi:10.1007/s00223-023-01096-x · Cited by 18
Osteoimmunology of Spondyloarthritis
Fassio, A., Atzeni, F., Rossini, M., D’Amico, V., Cantatore, F. P., Chimenti, M. S., Crotti, C., Frediani, B., Giusti, A., Peluso, G., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914924 · Cited by 18
HSP90 Exacerbates Bone Destruction in Rheumatoid Arthritis by Activating TRAF6/NFATc1 Signaling
Wang, Q., Kong, X., Guo, W., Liu, L., Tian, Y.-G., Tao, X., Lin, N., & Su, X. (2023) · Inflammation · doi:10.1007/s10753-023-01914-2 · Cited by 17
Sobacchi, C., & Abinun, M. (2022) · Bone · doi:10.1016/j.bone.2022.116541 · Cited by 18
Xia, X., Zhu, J., Xu, X., Wang, W., Zhao, R., Wu, K., Huang, H., Qian, Y., Luo, Z., Xu, F., et al. (2025) · Annals of Medicine · doi:10.1080/07853890.2025.2549524 · Cited by 23
Su, M., Ono, K., Kezuka, D., Miyamoto, S., Mori, Y., & Takai, T. (2022) · International Immunology · doi:10.1093/intimm/dxac051 · Cited by 16
Yoshimoto, S., Morita, H., Okamura, K., Hiraki, A., & Hashimoto, S. (2023) · Laboratory Investigation · doi:10.1016/j.labinv.2022.100023 · Cited by 16
Ma, Q., Wang, S., Xue, H., Ni, L., Yuan, P., Shen, Y., Zheng, B., Wang, Q., Zhang, J., Wang, H., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-61938-0 · Cited by 16
“signaling pathways suchasMAPKs and NF-κ B, leading to the activation of master transcription factors including PU.1 and NFATc1, initiating osteoclastogenesis 9,10 .”
CSTA plays a role in osteoclast formation and bone resorption by mediating the DAP12/TREM2 pathway
Wei, R., Zhang, L., Hu, W., Wu, J., & Zhang, W. J. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.08.033 · Cited by 15
Huang, S. ‐., Liu, Y., Wang, C., Xiang, W., Wang, N., Peng, L., Jiang, X., Zhang, X., & Fu, Z. (2023) · Orthopaedic Surgery · doi:10.1111/os.13848 · Cited by 15
Monteiro, A. C., Garcia, D. D., Rocher, B. D., Fontão, A. P. G. A., Nogueira, L. P., Fidalgo, G., Colaço, M. V., & Bonomo, A. C. (2023) · Bone · doi:10.1016/j.bone.2023.116932 · Cited by 17
Elson, A., Stein, M., Rabie, G., Barnea, M., Winograd-Katz, S. E., Reuven, N. B., Shalev, M., Sekereš, J., Kanaan, M. N., Tuckermann, J. P., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.671210 · Cited by 15
Regulation of osteoclast-mediated bone resorption by lipids
Luo, F., Chen, T., Chen, S., Bai, D., & Li, X. (2025) · Bone · doi:10.1016/j.bone.2025.117423 · Cited by 13
Menger, M. M., Manuschewski, R., Hans, S., Braun, B. J., Kayali, M. K. D. E., Ehnert, S., Ampofo, E., Wrublewsky, S., Menger, M. D., Histing, T., et al. (2025) · GeroScience · doi:10.1007/s11357-025-01584-y · Cited by 12
Roles and mechanisms of optineurin in bone metabolism
Jin, J., Huang, R., Chang, Y., & Yi, X. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116258 · Cited by 14
Castro, D. M., Lamana, A., Arribas‐Castaño, P., Gutiérrez‐Cañas, I., Villanueva‐Romero, R., Pérez‐García, S., Martínez, C., Juarranz, Y., de Córdoba‐Oñate, S. F., González‐Álvaro, I., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9121880 · Cited by 11
He, Q., Fu, K., Yao, H., Wei, S., Li, X., Liu, S., Chen, T., & Gao, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.983884 · Cited by 11
Choukroun, É., Parnot, M., Surmenian, J., Gruber, R., Cohen, N., Davido, N., Simonpieri, A., Savoldelli, C., Afota, F., Mjabber, H. E., et al. (2024) · Bioengineering · doi:10.3390/bioengineering11020191 · Cited by 13
Macrophages and osteoclasts: similarity and divergence between bone phagocytes
Halper, J., Dolfi, B., Ivanov, S., Madel, M., & Blin‐Wakkach, C. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1683872 · Cited by 12
Chen, C., Zong, S., Wang, Z., Yang, R., Guo, Y., Wang, Y., Chen, X., Li, Y., & Wang, S. (2023) · Journal of Immunology Research · doi:10.1155/2023/8571649 · Cited by 12
Role of MOTS-c in the regulation of bone metabolism
Yi, X., Hu, G., Yang, Y., Li, J., Jin, J., & Chang, B. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1149120 · Cited by 10
FAM19A5 in vascular aging and osteoporosis: Mechanisms and the “calcification paradox”
Zheng, J., He, J., & Li, H. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102361 · Cited by 10
Zeng, H., Li, D., He, Q., Zheng, X., Chen, X., Jian, G., Zhang, H., & Chen, T. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.101777 · Cited by 10
Pathogenesis, assessment, and management of bone loss in axial spondyloarthritis
Nakamura, A., & Towheed, T. (2023) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2023.152345 · Cited by 11
The Biological Properties of Co‐Doped Monetite Are Influenced by Thermal Treatment
de Almeida, G. S., Suter, L. C., Pinto, T. S., Carra, M. G. J., Feltran, G. D. S., de Moraes, J. F., Corrêa, D. R. N., Saeki, M. J., Lisboa‐Filho, P. N., & Zambuzzi, W. F. (2025) · Journal of Biomedical Materials Research Part B Applied Biomaterials · doi:10.1002/jbm.b.35531 · Cited by 9
Rare coding variants in NOX4 link high ROS levels to psoriatic arthritis mutilans
Wang, S., Nikamo, P., Laasonen, L., Guðbjörnsson, B., Ejstrup, L., Iversen, L., Lindqvist, U. R. C., Alm, J. J., Eisfeldt, J., Zheng, X., et al. (2024) · EMBO Molecular Medicine · doi:10.1038/s44321-024-00035-z · Cited by 9
Dantrolene, a stabilizer of the ryanodine receptor, prevents collagen-induced arthritis
Nawata, T., Sakai, H., Honda, T., Otsuka, M., Fujita, H., Uchinoumi, H., Kobayashi, S., Yamamoto, T., Asagiri, M., & Yano, M. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.07.111 · Cited by 9
Zhang, B., Luo, S., Wu, S., Li, J., He, F., Luo, R., Wu, Y., Pan, M., Yong, L., & Pei, X. (2023) · Chemistry & Biodiversity · doi:10.1002/cbdv.202201157 · Cited by 9
Ramani, H., Cleret‐Buhot, A., Sylla, M., Bunet, R., Bertrand, F., Peet, M.-M., Chartrand‐Lefebvre, C., Trottier, B., Thomas, R., Routy, J., et al. (2025) · Cells · doi:10.3390/cells14070481 · Cited by 9
Zhang, Y., Wang, Y., Zhang, X., Yue, L., Yang, L., Lai, H., Yang, C., & Huang, Y. (2025) · Nano Letters · doi:10.1021/acs.nanolett.5c01949 · Cited by 8
Garcia-Hernandez, M. D. L. L., Rangel-Moreno, J., García-Castañeda, M., Kenney, H., Paine, A., Thullen, M., Anandarajah, A., Schwarz, E., Dirksen, R., & Ritchlin, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1026574 · Cited by 9
Tong, X., Min, W., Li, S., Chen, M., Song, R., Bian, J., Gu, J., & Liu, Z. (2021) · Differentiation · doi:10.1016/j.diff.2021.08.003 · Cited by 8
Effect of cadmium on Rho GTPases signal transduction during osteoclast differentiation
He, S., Zhang, K., Cao, Y., Liu, G., Zou, H., Song, R., & Liu, Z. (2022) · Environmental Toxicology · doi:10.1002/tox.23510 · Cited by 8
Yang, F., Su, Y., Liang, J., Wang, K., Lian, H., Chen, J., Xu, J., Zhao, J., & Liu, Q. (2023) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2023.5246 · Cited by 8
Liu, J., Liu, Y., Fan, S., Yang, J., Xu, M., Zhao, L., Liu, C., Xing, Y., & Kong, X. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1538710 · Cited by 7
Liu, Z., Xi, X.-L., Wu, T.-R., Lu, Y., Zhong, P., Hu, Y., & Shen, X. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115339 · Cited by 7
The Therapeutic Effect of Natural Compounds on Osteoporosis through Ferroptosis
Zhang, Y., Qu, Z., Zhao, Y., Zhang, B., Gong, Y., Wang, X., Gao, X., Wang, D., & Yan, L. W. (2023) · Current Medicinal Chemistry · doi:10.2174/0109298673258420230919103405 · Cited by 9
Hong, G., Zhou, L., Zheng, G., Zheng, X., Chen, Z., He, W., & Wei, Q. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1287827 · Cited by 7
Regulatory mechanisms of autophagy-related ncRNAs in bone metabolic diseases
Yan, B., Li, Z., Su, H., Xue, H., Qiu, D., Xu, Z., & Tan, G. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1178310 · Cited by 8
Lu, W., Qi, G., Yang, X., Li, D., Chen, W., Zeng, Q., & Jiang, Z. (2023) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2023.12.011 · Cited by 7
The impact and mechanism of nerve injury on bone metabolism
Zhang, Y., Zhao, X. X., Ge, D., Huang, Y., & Yao, Q. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.149699 · Cited by 8
Isoginkgetin Inhibits RANKL-induced Osteoclastogenesis and Alleviates Bone Loss
Wang, Z., Deng, W., Tang, K., Zhou, Y., Chen, J., Wang, B., Zhang, Z., Zou, J., & Zhao, W. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116673 · Cited by 6
Burciaga, S. D., Saavedra, F. M., Fischer, L. A., Johnstone, K. F., & Jensen, E. D. (2023) · Bone · doi:10.1016/j.bone.2023.116759 · Cited by 6
Zhang, X., Miao, J., Song, Y., Zhang, J., & Miao, M. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e37894 · Cited by 5
The unexplored relationship between spontaneous osteoclastogenesis and platelets in osteoporosis
Salamanna, F., Martino, A. C. D., Contartese, D., Faldini, C., Giavaresi, G., & Fini, M. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1584022 · Cited by 5
Monteiro, A. C., Garcia, D. D., Fontão, A. P. G. A., Rocher, B. D., Masset, M. E. G., Alves, I. B., Carvalho, L. G., de Andrade, C. V., Fidalgo, G., Colaço, M. V., et al. (2025) · Cancer Research Communications · doi:10.1158/2767-9764.crc-25-0696 · Cited by 5
Beyond bone effects: the role of denosumab in muscle Health – A systematic review
Ceolin, C., Ziliotto, C., Papa, M. V., Bertocco, A. G., Sergi, G., & RUI, M. D. (2026) · Aging Clinical and Experimental Research · doi:10.1007/s40520-025-03285-0 · Cited by 6
Phosphatidyl Inositol 3-Kinase (PI3K)-Inhibitor CDZ173 protects against LPS-induced osteolysis
Wu, Z., Li, X., Chen, X., He, X., Chen, Y., Zhang, L., Li, Z., Yang, M., Yuan, G., Shi, B., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1021714 · Cited by 5
Leucine‐rich alpha‐2‐glycoprotein 1 affects bone destruction via IL ‐6 in mouse periodontitis model
Ouhara, K., Takemura, T., Taniguchi, Y., Fujimori, R., Tamura, T., Akane, Y., Matsuda, S., Hamamoto, Y., Shintani, T., Kajiya, M., et al. (2024) · Oral Diseases · doi:10.1111/odi.14952 · Cited by 5
Ferritin was involved in interleukin-17A enhanced osteogenesis through autophagy activation
Yuan, W., Yang, Y., Wei, Y., Yu, X., Bao, J., Zhong, J., Wang, Z., & Chen, L. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110916 · Cited by 5
Ok, C. Y., Kwon, R. J., Jang, H.-O., Bae, M., & Bae, S. (2024) · Biomolecules · doi:10.3390/biom14121500 · Cited by 6
Unraveling the Mechanisms That Regulate Osteoclast Differentiation: A Review of Current Advances
Zhang, S., Gao, M., Song, S., Zhao, T., Zhou, B.-H., Wang, H., Tian, W., Zhao, W., & Zhao, J. (2025) · genesis · doi:10.1002/dvg.70012 · Cited by 7
Tackling myeloma bone disease: From pathophysiology to cutting-edge therapies
Roux, S., Debiais, F., & Vieillard, M.-H. (2025) · Blood Reviews · doi:10.1016/j.blre.2025.101305 · Cited by 7
Wirsig, K., Bürger, N., & Bernhardt, A. (2025) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-025-00793-9 · Cited by 6
Osteoimmune senescence in aging-related bone diseases
Li, H., Yang, Y., & Zhu, H. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1892334 · Cited by 5
Vallone, V. B. F., Borzone, F. R., Martinez, L. M., Giorello, M. B., Choi, H., Dimase, F., Feldman, L. J., Bordenave, R. H., Chudzinski‐Tavassi, A. M., Batagelj, E., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1073793 · Cited by 5
Pan, Z., Li, F., Xu, Y.-J., Ye, H., Liu, J., Wang, Z., Deng, C., Song, J., Mei, M., & Li, C. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1423884 · Cited by 5
Razavi, A. H., Nafisi, N., Hammerle, M. V. V., Shariyate, M. J., Khak, M., Mirahmadi, A., McNichol, M. C., Rodrogiuez, E. K., & Nazarian, A. (2025) · Biomechanics and Modeling in Mechanobiology · doi:10.1007/s10237-025-01938-7 · Cited by 4
Overexpression of Neurogenin 1 Negatively Regulates Osteoclast and Osteoblast Differentiation
Kim, J. H., Kim, K., Kim, I., Seong, S., Koh, J., & Kim, N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126708 · Cited by 5
Cellular ROS tolerance determines the effect of plumbagin on osteoclast differentiation
Sultanli, S., Schneider, J., Burkart, S. S., Binder, M., & Kubatzky, K. F. (2023) · The FASEB Journal · doi:10.1096/fj.202301415r · Cited by 4
Wei, S.-G., Chen, H.-H., Xie, L.-R., Qin, Y., Mai, Y., Huang, L., & Liao, H. (2025) · World Journal of Stem Cells · doi:10.4252/wjsc.v17.i4.101290 · Cited by 3
Ormsby, R. T., Zhang, Y., Hodys, C., Wake, L. A., Perez, S. M., Tsang, K., Yang, Y., & Charles, J. F. (2025) · JBMR Plus · doi:10.1093/jbmrpl/ziaf145 · Cited by 3
Cobalt‐Doped Monetite‐Induced Biomimetic Hypoxia Camouflages Osteogenic Healing Microenvironment
de Almeida, G. S., Pinto, T. S., Suter, L. C., Feltran, G. D. S., Carra, M. G. J., de Moraes, J. F., Corrêa, D. R. N., Lisboa‐Filho, P. N., Saeki, M. J., & Zambuzzi, W. F. (2025) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.37984 · Cited by 3
Metadata
- Authors
- Takayanagi, H.
- Affiliations
- The University of Tokyo (JP)
- Corresponding author
- Takayanagi, Hiroshi
- ORCID
- Takayanagi, Hiroshi
- Venue
- Journal of Bone and Mineral Metabolism
- Published
- 2021-01
- Volume
- 39
- Issue
- 1
- Pages
- 13-18
- ISSN
- 0914-8779 (ISSN-L)
- 1435-5604
- OpenAlex
- W3116940347
- Cited by
- 175
- References
- 43
- Citations by year
- 2026: 29 · 2025: 38 · 2024: 35 · 2023: 38 · 2022: 25 · 2021: 9
- FWCI
- 2.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Bone and Mineral Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Japan Society for the Promotion of Science (20F20730)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Health Sciences › Medicine › Rheumatology › Osteomyelitis and Bone Disorders Research
- Keywords
- RANKL, osteoclastogenesis, RANK receptor, costimulatory receptors, NFATc1, transcription factor signaling, osteoblasts, osteocytes, bone remodeling
- MeSH terms
- Animals, Humans, Osteoblasts, Osteoclasts, Osteogenesis, Signal Transduction, NFATC Transcription Factors, RANK Ligand
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review